Suppr超能文献

含阿莫西林的用于清除幽门螺杆菌的黏膜黏附微球。

Mucoadhesive microspheres containing amoxicillin for clearance of Helicobacter pylori.

作者信息

Nagahara N, Akiyama Y, Nakao M, Tada M, Kitano M, Ogawa Y

机构信息

DDS Research Laboratories, Pharmaceutical Research Division, Takeda Chemical Industries, Ltd., Osaka, Japan.

出版信息

Antimicrob Agents Chemother. 1998 Oct;42(10):2492-4. doi: 10.1128/AAC.42.10.2492.

Abstract

In an effort to augment the anti-Helicobacter pylori effect of amoxicillin, mucoadhesive microspheres, which have the ability to reside in the gastrointestinal tract for an extended period, were prepared. The microspheres contained the antimicrobial agent and an adhesive polymer (carboxyvinyl polymer) powder dispersed in waxy hydrogenated castor oil. The percentage of amoxicillin remaining in the stomach both 2 and 4 h after oral administration of the mucoadhesive microspheres to Mongolian gerbils under fed conditions was about three times higher than that after administration in the form of a 0.5% methylcellulose suspension. The in vivo clearance of H. pylori following oral administration of the mucoadhesive microspheres and the 0.5% methylcellulose suspension to infected Mongolian gerbils was examined under fed conditions. The mucoadhesive microspheres and the 0.5% methylcellulose suspension both showed anti-H. pylori effects in this experimental model of infection, but the required dose of amoxicillin was effectively reduced by a factor of 10 when the mucoadhesive microspheres were used. In conclusion, the mucoadhesive microspheres more effectively cleared H. pylori from the gastrointestinal tract than the 0.5% methylcellulose suspension due to the prolonged gastrointestinal residence time resulting from mucoadhesion. A dosage form consisting of mucoadhesive microspheres containing an appropriate antimicrobial agent should be useful for the eradication of H. pylori.

摘要

为了增强阿莫西林的抗幽门螺杆菌作用,制备了具有在胃肠道中长期停留能力的黏膜黏附微球。这些微球含有抗菌剂和分散在蜡质氢化蓖麻油中的黏附聚合物(羧乙烯基聚合物)粉末。在喂食条件下,给蒙古沙鼠口服黏膜黏附微球后2小时和4小时,胃中残留的阿莫西林百分比比以0.5%甲基纤维素混悬液形式给药后高出约三倍。在喂食条件下,研究了给感染的蒙古沙鼠口服黏膜黏附微球和0.5%甲基纤维素混悬液后幽门螺杆菌的体内清除情况。在该感染实验模型中,黏膜黏附微球和0.5%甲基纤维素混悬液均显示出抗幽门螺杆菌作用,但使用黏膜黏附微球时,所需的阿莫西林剂量有效降低了10倍。总之,由于黏膜黏附导致胃肠道停留时间延长,黏膜黏附微球比0.5%甲基纤维素混悬液更有效地从胃肠道清除幽门螺杆菌。由含有适当抗菌剂的黏膜黏附微球组成的剂型应有助于根除幽门螺杆菌。

相似文献

引用本文的文献

本文引用的文献

2

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验